MANUFACTURING FACILITIES ISSUE

This adverse event was reported 11 times

MANUFACTURING FACILITIES ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SULFACETAMIDE SODIUM, SULFUR 1 0.0087
1 DORNASE ALFA 1 0.0001
2 TOBRAMYCIN 1 0.0000
3 PAROXETINE HYDROCHLORIDE HEMIHYDRATE 1 0.0000
4 PANCRELIPASE 1 0.0000
5 PAROXETINE HYDROCHLORIDE 1 0.0000
6 DIAZEPAM ORAL 1 0.0000
7 DIAZEPAM 1 0.0000
8 CARBOPLATIN 1 0.0000
9 CETIRIZINE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with MANUFACTURING FACILITIES ISSUE

MANUFACTURING FACILITIES ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Deoxyribonuclease 1 [EPC] 1 0.0001
1 Aminoglycoside Antibacterial [EPC] 1 0.0000
2 Platinum-based Drug [EPC] 1 0.0000
3 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
4 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
5 Atypical Antipsychotic [EPC] 1 0.0000
6 Benzodiazepine [EPC] 1 0.0000
See all drug classes enriched for association with MANUFACTURING FACILITIES ISSUE